Understanding the Molecular Drivers of Disease Heterogeneity in Crohn's Disease Using Multi-omic Data Integration and Network Analysis.

CD4+ T cells Crohn’s disease blood clinical phenotypes data integration drug repurposing drug targets gene expression genetics heterogeneity hubs monocytes networks systems biology

Journal

Inflammatory bowel diseases
ISSN: 1536-4844
Titre abrégé: Inflamm Bowel Dis
Pays: England
ID NLM: 9508162

Informations de publication

Date de publication:
17 05 2021
Historique:
received: 10 03 2020
pubmed: 15 12 2020
medline: 9 2 2022
entrez: 14 12 2020
Statut: ppublish

Résumé

Crohn's disease (CD), a form of inflammatory bowel disease (IBD), is characterized by heterogeneity along multiple clinical axes, which in turn impacts disease progression and treatment modalities. Using advanced data integration approaches and systems biology tools, we studied the contribution of CD susceptibility variants and gene expression in distinct peripheral immune cell subsets (CD14+ monocytes and CD4+ T cells) to relevant clinical traits. Our analyses revealed that most clinical traits capturing CD heterogeneity could be associated with CD14+ and CD4+ gene expression rather than disease susceptibility variants. By disentangling the sources of variation, we identified molecular features that could potentially be driving the heterogeneity of various clinical traits of CD patients. Further downstream analyses identified contextual hub proteins such as genes encoding barrier functions, antimicrobial peptides, chemokines, and their receptors, which are either targeted by drugs used in CD or other inflammatory diseases or are relevant to the biological functions implicated in disease pathology. These hubs could be used as cell type-specific targets to treat specific subtypes of CD patients in a more individualized approach based on the underlying biology driving their disease subtypes. Our study highlights the importance of data integration and systems approaches to investigate complex and heterogeneous diseases such as IBD.

Identifiants

pubmed: 33313682
pii: 6032729
doi: 10.1093/ibd/izaa281
pmc: PMC8128416
doi:

Substances chimiques

Antimicrobial Peptides 0
Chemokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

870-886

Subventions

Organisme : European Research Council
ID : 694679
Pays : International

Informations de copyright

© 2020 Crohn’s & Colitis Foundation. Published by Oxford University Press on behalf of Crohn’s & Colitis Foundation.

Références

IEEE Trans Neural Netw Learn Syst. 2015 Sep;26(9):2136-47
pubmed: 25532193
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4245-50
pubmed: 23431203
Am J Physiol Gastrointest Liver Physiol. 2016 Feb 1;310(3):G155-62
pubmed: 26608188
Nat Genet. 2017 Feb;49(2):262-268
pubmed: 28067912
Nat Commun. 2014;5:3231
pubmed: 24488081
Bioinformatics. 2014 Sep 1;30(17):i497-504
pubmed: 25161239
Pharmacol Res Perspect. 2019 Nov 15;7(6):e00537
pubmed: 31832202
J Immunol. 2005 Feb 15;174(4):2343-52
pubmed: 15699171
Nat Rev Gastroenterol Hepatol. 2015 Dec;12(12):672
pubmed: 26526125
PeerJ. 2017 Aug 14;5:e3678
pubmed: 28828272
Nature. 2012 Nov 1;491(7422):119-24
pubmed: 23128233
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):224-234
pubmed: 28404137
PLoS One. 2013 Jul 26;8(7):e69839
pubmed: 23922818
J Clin Invest. 2011 Oct;121(10):4170-9
pubmed: 21946256
BMC Bioinformatics. 2018 Feb 20;19(1):56
pubmed: 29458351
J Cell Sci. 2005 Nov 1;118(Pt 21):4947-57
pubmed: 16254242
Lancet. 2016 Jan 9;387(10014):156-67
pubmed: 26490195
Biochem Biophys Res Commun. 2015 Sep 4;464(4):1314-1320
pubmed: 26232643
Bioinformatics. 2010 May 1;26(9):1267-8
pubmed: 20305269
Gut. 2018 Jan;67(1):36-42
pubmed: 27742763
Nat Genet. 2016 Aug;48(8):838-47
pubmed: 27322546
Cell. 2013 Nov 21;155(5):1178-87
pubmed: 24267896
Gastroenterol Jpn. 1992 Feb;27(1):29-36
pubmed: 1555746
PLoS Genet. 2017 Apr 13;13(4):e1006402
pubmed: 28406900
FASEB J. 2012 Mar;26(3):1290-300
pubmed: 22106366
BMC Syst Biol. 2016 Aug 01;10 Suppl 2:51
pubmed: 27490697
Leukemia. 2005 Nov;19(11):2002-5
pubmed: 16121219
Haematologica. 2013 Jul;98(7):1115-23
pubmed: 23349302
BMC Bioinformatics. 2006 Nov 20;7:509
pubmed: 17116249
Nat Med. 2007 May;13(5):587-96
pubmed: 17435771
Nucleic Acids Res. 2019 Jul 2;47(W1):W212-W224
pubmed: 31114921
Bioinformatics. 2015 Nov 1;31(21):3413-20
pubmed: 26148744
J Crohns Colitis. 2018 Mar 28;12(4):465-475
pubmed: 29211912
Ann Transl Med. 2015 Mar;3(3):34
pubmed: 25815295
FEBS Lett. 1996 Jul 15;390(1):69-72
pubmed: 8706832
Blood. 2008 Sep 1;112(5):1557-69
pubmed: 18725574
J Immunol. 2011 Jul 1;187(1):181-9
pubmed: 21606247
PLoS One. 2013 Apr 26;8(4):e62761
pubmed: 23658649
Immunol Rev. 2013 Mar;252(1):164-82
pubmed: 23405904
Curr Protoc Bioinformatics. 2014 Sep 08;47:8.13.1-24
pubmed: 25199793
Immunity. 2000 Oct;13(4):561-71
pubmed: 11070174
BMC Bioinformatics. 2010 Oct 06;11:497
pubmed: 20925918
Science. 2009 Jul 24;325(5939):412-3
pubmed: 19628854
PLoS Comput Biol. 2020 Apr 6;16(4):e1007800
pubmed: 32251445
Nucleic Acids Res. 2011 Jan;39(Database issue):D691-7
pubmed: 21067998
Brief Bioinform. 2018 Jul 20;19(4):575-592
pubmed: 28077403
PLoS One. 2009 Nov 24;4(11):e7984
pubmed: 19956723
Genome Res. 2019 Aug;29(8):1363-1375
pubmed: 31340985
J Immunol. 2016 Oct 15;197(8):3086-3098
pubmed: 27655845
Cell. 1994 Jan 28;76(2):301-14
pubmed: 7507411
Immunology. 1988 May;64(1):1-9
pubmed: 2454881
Bioinformatics. 2019 Dec 15;35(24):5339-5340
pubmed: 31347689
Blood. 2010 Jun 17;115(24):5061-8
pubmed: 20393130
J Cell Physiol. 2015 Aug;230(8):1740-9
pubmed: 25215878
G3 (Bethesda). 2012 Sep;2(9):987-1002
pubmed: 22973536
Sci Rep. 2016 Jul 15;6:29783
pubmed: 27417573
Can J Gastroenterol. 2005 Sep;19 Suppl A:5A-36A
pubmed: 16151544
Nucleic Acids Res. 2019 Jan 8;47(D1):D1056-D1065
pubmed: 30462303
Nat Med. 2006 Oct;12(10):1203-7
pubmed: 16964257
Cell Syst. 2018 Apr 25;6(4):484-495.e5
pubmed: 29605183
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Clin Transl Gastroenterol. 2016 Jun 23;7(6):e177
pubmed: 27336838
Front Immunol. 2018 Jun 01;9:1212
pubmed: 29910812
J Crohns Colitis. 2019 Feb 1;13(2):144-164
pubmed: 30137275
Gastroenterology. 2018 Oct;155(4):1079-1089.e3
pubmed: 29958857
Gut. 1961 Jun;2:110-8
pubmed: 13696345
Cytokine. 1993 Sep;5(5):407-15
pubmed: 8142595
Immunology. 2013 Sep;140(1):87-97
pubmed: 23600521
Inflamm Bowel Dis. 2015 Nov;21(11):2515-32
pubmed: 26313691
Gut. 2013 Nov;62(11):1653-64
pubmed: 24104886
J Leukoc Biol. 2017 Nov;102(5):1271-1280
pubmed: 28899907
J Exp Med. 1993 Aug 1;178(2):669-74
pubmed: 7688031
Cell. 2010 Jun 25;141(7):1135-45
pubmed: 20602997
Cell. 2015 Jan 29;160(3):447-60
pubmed: 25619688
Bioinformatics. 2016 Aug 15;32(16):2457-63
pubmed: 27153643
Exp Mol Med. 2017 Aug 4;49(8):e364
pubmed: 28775365
Am J Hum Genet. 2002 Apr;70(4):845-57
pubmed: 11875755
Inflamm Bowel Dis. 2009 May;15(5):697-706
pubmed: 19067429
EMBO Mol Med. 2018 Aug;10(8):
pubmed: 29941542
Bioinformatics. 2010 Jan 15;26(2):205-14
pubmed: 19910304
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
Cell Mol Immunol. 2015 Mar;12(2):222-30
pubmed: 24976267
Nature. 2015 Jul 30;523(7562):612-6
pubmed: 26123020
Mucosal Immunol. 2019 May;12(3):703-719
pubmed: 30670762
Nature. 2015 Feb 19;518(7539):337-43
pubmed: 25363779
Inflamm Bowel Dis. 2017 Oct;23(10):1718-1729
pubmed: 28885228
BMC Bioinformatics. 2018 Jan 15;19(1):11
pubmed: 29334888
Am J Gastroenterol. 2011 Apr;106(4):748-61
pubmed: 21326222
Proc Natl Acad Sci U S A. 2015 Nov 10;112(45):14000-5
pubmed: 26512113
J Dig Dis. 2018 Nov;19(11):678-684
pubmed: 30284387
Cytokine. 2008 Aug;43(2):181-6
pubmed: 18579408
Immunity. 2015 Dec 15;43(6):1125-36
pubmed: 26682985
J Biol Chem. 1999 Feb 26;274(9):5835-42
pubmed: 10026206
Glycobiology. 2016 Jan;26(1):13-8
pubmed: 26369908
J Gastroenterol Hepatol. 2014 Oct;29(10):1808-14
pubmed: 24720272
J Gastroenterol. 2016 Oct;51(10):939-48
pubmed: 26831355
BioDrugs. 2019 Feb;33(1):15-32
pubmed: 30701418
Dis Mon. 2018 Feb;64(2):20-57
pubmed: 28826742
Mol Syst Biol. 2018 Jun 20;14(6):e8124
pubmed: 29925568
Ann Rheum Dis. 2015 Jun;74(6):1311-6
pubmed: 25398374
Front Immunol. 2017 Mar 14;8:258
pubmed: 28352268
J Interferon Res. 1994 Oct;14(5):235-8
pubmed: 7861027

Auteurs

Padhmanand Sudhakar (P)

Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID).

Bram Verstockt (B)

Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID).
University Hospitals Leuven, Department of Gastroenterology and Hepatology.

Jonathan Cremer (J)

Department of Microbiology and Immunology, Laboratory of Clinical Immunology, Katholieke Universiteit Leuven, Leuven, Belgium.

Sare Verstockt (S)

Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID).

João Sabino (J)

Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID).
University Hospitals Leuven, Department of Gastroenterology and Hepatology.

Marc Ferrante (M)

Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID).
University Hospitals Leuven, Department of Gastroenterology and Hepatology.

Séverine Vermeire (S)

Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID).
University Hospitals Leuven, Department of Gastroenterology and Hepatology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH